EU court ruling removes another obstacle to stem cell patenting
This article was originally published in Scrip
Executive Summary
In a decision that will be welcomed by the biotechnology industry, the Court of Justice of the EU has ruled that a parthenote – an unfertilized human ovum stimulated to grow by parthenogenesis – is not capable of developing into a human being and so can be patented.